That is mostly outside our scope because we don't know how this program would actually be implemented. The cost estimate just reflects what the government would be paying, assuming that these drugs would be purchased at a pharmacy and then patients would seek reimbursement. The federal government would pay for that.
On October 17th, 2017. See this statement in context.